Tebipenem (SPR994) Tissue Penetration in Diabetic Patients With Wound Infections and Healthy Volunteers Via In Vivo Microdialysis
Clinical trial NCT04919954 · COMPLETED
Trial details
- NCT number
- NCT04919954
- Sponsor
- Hartford Hospital
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-01
- Primary completion
- 2022-08-30
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.